BIOTECH LATEST
Since the peak of 2015 until recently we have seen the NBI trade within a range where it tested the lower support 3 times without breaking it. We have also been encouraged by the string of good fundamental developments including several clinical trial successes and M&A activity.
These two points give us strong confidence in the performance of the sector through the end of the year and 2023.
